Dr. Christine Harter, MD is a Internist in Glendale, AZ with over 16 years of experience. What is your opinion of Dr. Christine Harter, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Christine Harter, MD has received over $82,705 which includes payments from the following companies:
$23,380.69 from Allergan Inc.
$18,001.88 from LILLY USA, LLC
$11,743.35 from Teva Pharmaceuticals USA, Inc.
$10,418.63 from Supernus Pharmaceuticals, Inc.
$5,523.03 from Novartis Pharmaceuticals Corporation
$4,484.29 from Upsher-Smith Laboratories Inc.
$2,755.89 from Promius Pharma LLC
$1,035.08 from Amgen Inc.
$659.87 from AstraZeneca Pharmaceuticals LP
$595.14 from Pernix Therapeutics Holdings, Inc.
$498.75 from Depomed, Inc.
$429.05 from Avanir Pharmaceuticals, Inc.
$317.06 from Impax Laboratories, Inc.
$268.57 from Valeant Pharmaceuticals North America LLC
$258.29 from Merck Sharp & Dohme Corporation
$195.67 from Egalet US Inc
$191.00 from AbbVie, Inc.
$167.52 from Novo Nordisk Inc
$158.61 from Pfizer Inc.
$146.60 from AKRIMAX PHARMACEUTICALS, LLC
Payments received by Dr. Christine Harter, MD were from the following categories:
$41,150.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!